191
Participants
Start Date
March 31, 2010
Primary Completion Date
July 31, 2010
Indacaterol
Indacaterol inhaled via Concept1, a single dose dry powder inhaler (SDDPI) for 16 days. Dosage and frequency varied according to randomization scheme.
Placebo to Indacaterol
Placebo inhaled via Concept1, a SDDPI. Frequency varied according to randomization scheme.
Novartis Investigative Site, Raleigh
Novartis Investigative Site, Miami
Novartis Investigative Site, Miami
Novartis Investigative Site, Tampa
Novartis Investigative Site, Clearwater
Novartis Investigative Site, Sarasota
Novartis Investigative Site, Anniston
Novartis Investigative Site, Normal
Novartis Investigative Site, Lafayette
Novartis Investigator Site, Oklahoma City
Novartis Investigative Site, Plano
Novartis Investigative Site, Houston
Novartis Investigative Site, San Antonio
Novartis Investigative Site, Denver
Novartis Investigative Site, Las Vegas
Novartis Investigative Site, Cypress
Novartis Investigative Site, San Diego
Novartis Investigative Site, Fresno
Novartis Investigative Site, Tacoma
Novartis Investigative Site, Tacoma
Novartis Investigative Site, Berlin
Novartis Investigative Site, Paris
Novartis Investigative Site, Rennes
Novartis Investigative Site, Wiesbaden
Novartis Investigative Site, Amman
Novartis Investigative Site, Irbid
Novartis Investigative Site, Groningen
Novartis Investigative Site, London
Novartis Investigative Site, Manchester
Novartis Investigative Site, Merthyr Tydfil
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY